DNA Script Partners with Moderna to Develop On‐Demand Vaccines and Therapeutics for DARPA DNA Script, a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science, is partnering with Moderna to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced…..
Evonik delivers first lipids from German facility to BioNTech The German company Evonik is delivering first batches of urgently needed lipids used in production of COVID-19 vaccine to BioNTech on April 22. Initially, delivery was scheduled to start in the middle of the year. But, specialists at Evonik’s Hanau site…..
New study expands evaluation of gene therapy for spinal muscular atrophy German researchers have just published results of a retrospective analysis of routine data collected from all patients with spinal muscular atrophy (SMA) treated with Zolgensma® (onasemnogene abeparvovec - adeno-associated viral (AAV9) vector-based gene therapy that introduces a functional copy…..
Celonic will manufacture over 100 million doses of Curevac's COVID-19 Vaccine Candidate, CVnCoV CureVac and Celonic Group have conclud a partnership for the production of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV. CureVac began development of mRNA-based COVID-19 vaccine candidates in January 2020 and CVnCoV is the vaccine candidate chosen for…..
ConserV Bioscience and eTheRNA immunotherapies to Collaborate on Development of mRNA Vaccines for Infectious Diseases ConserV Bioscience, a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and eTheRNA, a clinical-stage immunotherapy company focused on mRNA antigen delivery and immunostimulation using its TriMix technology,…..
Biogen plans to build a new gene therapy manufacturing facility in Research Triangle Park Biogen, a pioneer in neurosciences, plans to build a new gene therapy manufacturing facility at its Research Triangle Park (RTP) manufacturing campuses in North Carolina to support its growing gene therapy pipeline across multiple therapeutic areas.…..
VIVEbiotech expands facilities to increase innovation and manufacturing capabilities of specialist lentiviral vectors VIVEbiotech, a Spanish CDMO focused on the manufacture of lentiviral vectors from R&D early stages to GMP, is expanding its manufacturing capabilities with new facilities. This expansion will enable increased production capacity and the further optimization of…..
Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein Celonic, a leading global CDMO, specialized in development and production of Advanced Therapy Medicinal Products (ATMP) and bio-therapeutics, announced a long-term lease agreement for a new production site and office…..
Hide-and-seek can lead to higher drug prices In Switzerland and other European countries, drug prices are regulated to ensure affordable access to drugs. In the last few years, many European countries have introduced rebate schemes for drugs. In most cases, however, the rebates negotiated with the manufacturer are confidential. This…..
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK Leading German CDMO for biopharmaceuticals, Rentschler Biopharma will establish their manufacturing capability in ATMPs, including Adeno-Assiociated Virus (AAV) vectors for clinical trial supply at the Cell and Gene Therapy (CGT) Catapult facility site in Stevenage. Under the…..
- Page Précédente
- 1
...
- 4
- 5
- 6
- 7
- 8
...
- 21
- Page Suivante
